MYD88,CD79B, andCARD11gene mutations in CD5-positive diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

MYD88,CD79B, andCARD11gene mutations in CD5-positive diffuse large B-cell lymphoma

Published:2016-12-04 Issue:7 Volume:123 Page:1166-1173
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Takeuchi Toshifumi¹,Yamaguchi Motoko¹,Kobayashi Kyoko¹,Miyazaki Kana¹,Tawara Isao¹,Imai Hiroshi²,Ono Ryoichi³,Nosaka Tetsuya³,Tanaka Kyosuke⁴,Katayama Naoyuki¹

Affiliation:

1. Department of Hematology and Oncology; Mie University Graduate School of Medicine; Tsu Japan

2. Pathology Division; Mie University Hospital; Tsu Japan

3. Department of Microbiology and Molecular Genetics; Mie University Graduate School of Medicine; Tsu Japan

4. Department of Endoscopy; Mie University Hospital; Tsu Japan

Funder

the National Cancer Center Research and Development Fund

the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development (AMED)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. Oncogenically active MYD88 mutations in human lymphoma;Ngo;Nature,2011

2. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma;Davis;Nature,2010

3. Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma;Bohers;Genes Chromosomes Cancer,2014

4. Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas;Nakamura;Neuropathol Appl Neurobiol,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CD5+ diffuse large B-cell lymphoma;Annals of Hematology;2024-08-28

2. B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells;International Journal of Molecular Sciences;2023-12-19

3. Advances in diagnosis, treatment and prognostic factors of gastrointestinal DLBCL;Leukemia Research;2023-12

4. Chromosome 17;Cancer Genes: Volume 2;2023-08-16

5. Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases;Cancer Medicine;2023-07-27